SUBSCRIBE
SUBSCRIBE

Cavit Sciences, Inc. Announces Status of the Company’s Advancement of Tubercin

August 23, 2007 | 
1 min read

DELRAY BEACH, FL--(MARKET WIRE)--Aug 23, 2007 -- Cavit Sciences, Inc. (“Cavit”) (OTC BB:CVIT.OB - News) today announced the status of the Company’s advancement of Tubercin.